A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with attention deficit/hyperactivity disorder
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2012
At a glance
- Drugs Modafinil (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Cephalon
- 13 Nov 2007 Status changed from in progress to completed. Trial completion dated added from NCT DMS 15/11/07.
- 12 Nov 2006 New trial record.